Neuronetics Inc(STIM) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Neuronetics, Inc. commercial stage medical technology company. The company is headquartered in Malvern, Pennsylvania and currently employs 191 full-time employees. The firm is focused on the design and development of medical devices to treat psychiatric disorders. The Company’s principal product is NeuroStar Advanced Therapy System. The company is a non-invasive treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed magnetic field to induce electrical pulses for stimulating certain areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorders. The firm offers its therapy systems to psychiatrist offices in the United States.

Current Price

$13.15

RSI

63.458

Beta:

2.786912

March 02, 2021
69.2M
-1.8M

-10.239 %
-24.286 %
51.589 %
-14.297 %

$44,198,000
$59,671,000
$49,988,000
-35.008 %
19.371 %

$-27,453,000
$-29,044,000
$-24,097,000
5.795 %
-17.033 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.